Health Coaching, Continuous Glucose Monitoring and AI Mobile App in Diabetes

Phase

N/A

Condition

Diabetes Mellitus, Type 2

Diabetes And Hypertension

Diabetes Prevention

Treatment

EMPOWER mobile app

Continuous glucose monitoring and health coaching

Clinical Study ID

NCT06028139

202208-00017

Ages 21-100
All Genders

Study Summary

Lifestyle change is key to diabetes management but there are limited resources and time to support patients in improving lifestyle behaviour in the current healthcare system. Currently, health coaching for behavioural chance guided by continuous glucose data, wearable and lifestyle data is not available in primary and tertiary care management of diabetes. This parallel-group randomised controlled trial (RCT) aims to investigate the effectiveness of a novel multi-component model of care comprising interventions including the mobile app EMPOWER and smartwatch, health coaching, and continuous glucose monitoring (CGM).

Eligibility Criteria

Inclusion

Inclusion Criteria:

Aged 21 years and above
Have diagnosis of type 2 diabetes mellitus
Provided informed consent
Have near-field communication (NFC) compatible phones
Able to engage in light physical activity (e.g., walking)

Exclusion

Exclusion Criteria:

Significant cognitive impairment
Other conditions that may preclude participants from wearing CGM devices

Study Design

EMPOWER mobile app

October 24, 2023

December 31, 2024

Connect with a study center

National Heart Centre Singapore
Singapore,
Singapore
Active - Recruiting
Sengkang General Hospital
Singapore,
Singapore
Active - Recruiting
Singapore General Hospital
Singapore, 486838
Singapore
Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.